4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-059985
Chief Financial Officer sold 10,000 shares at an average $32.41 ($324,050)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-10-05 | Option exercise | +5,000 | $7.27 | $36,350 | 26,604 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2021-10-05 | Sale | −5,000 | $32.51 | $162,550 | 21,604 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2021-10-06 | Option exercise | +5,000 | $7.27 | $36,350 | 26,604 | D: show line 3 in the form |
| Cohen Chad M Chief Financial Officer | 2021-10-06 | Sale | −5,000 | $32.30 | $161,500 | 21,604 | D: show line 4 in the form |
| Open-market sales · 10,000 sh · avg $32.41 · $324,050 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-10-05 | Option exercise · Stock Option (Right to Buy) | −5,000 | 105,000 | D: show line 5 in the form | ||
| Cohen Chad M Chief Financial Officer | 2021-10-06 | Option exercise · Stock Option (Right to Buy) | −5,000 | 100,000 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…